InvestorsHub Logo
Followers 516
Posts 38725
Boards Moderated 5
Alias Born 04/26/2012

Re: None

Saturday, 01/12/2019 7:47:41 PM

Saturday, January 12, 2019 7:47:41 PM

Post# of 955
LEXINGTON, Mass., Jan. 4, 2019 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that on January 2, 2019, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase 30,000 shares of Curis common stock to a new employee, with a grant date of January 2, 2019 (the "Q1 2019 Inducement Grant").



:)

All my posts are my opinion only. Please do your due diligence on all your investments.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRIS News